Ivabradine–Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review

Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature research on the use of ivabradine in the treatment of pediatric junctional ectopic tachycardia (JET), both congenital and postoperative, and describe the successful use of ivabradine–flecainide association for CJET therapy resistant to other antiarrhythmic agents. This new drug combination was effective in completely suppressing JET. Ivabradine–flecainide combination may be considered a new therapeutic strategy of CJET with a satisfactory efficacy/tolerability ratio in patients resistant to conventional drug combinations.

[1]  N. Sharma,et al.  Use of ivabradine for treatment of junctional ectopic tachycardia in post congenital heart surgery , 2020, Indian Journal of Thoracic and Cardiovascular Surgery.

[2]  Suresh V. Joshi,et al.  Use of Ivabradine in the Treatment of Tachyarrhythmias After Surgery for Congenital Heart Diseases. , 2020, Journal of cardiothoracic and vascular anesthesia.

[3]  R. Samson,et al.  Junctional ectopic tachycardia in infants and children , 2019, Journal of arrhythmia.

[4]  Vivek Kumar,et al.  Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study , 2019, World journal for pediatric & congenital heart surgery.

[5]  M. Sahu,et al.  Ivabradine—The Final Crusader for Postoperative Junctional Ectopic Tachycardia, a Case Report with Literature Review , 2019, World Journal of Cardiovascular Surgery.

[6]  E. Ozturk,et al.  Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia‐induced cardiomyopathy during infancy: Case studies , 2018, Pacing and clinical electrophysiology : PACE.

[7]  S. Kothari,et al.  Ivabradine for congenital junctional ectopic tachycardia in siblings , 2018, Annals of pediatric cardiology.

[8]  G. Kumar,et al.  Ivabradine for junctional ectopic tachycardia in post congenital heart surgery , 2017, Indian heart journal.

[9]  T. Paul,et al.  Adjunctive ivabradine in combination with amiodarone: A novel therapy for pediatric congenital junctional ectopic tachycardia. , 2016, Heart rhythm.

[10]  M. Yoshinaga,et al.  Combination of flecainide and propranolol for congenital junctional ectopic tachycardia , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[11]  É. Marijon,et al.  Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  R. Hamilton,et al.  Potential New Indication for Ivabradine: Treatment of a Patient with Congenital Junctional Ectopic Tachycardia , 2013, Journal of cardiovascular electrophysiology.

[13]  M. Guglin.  Heart rate reduction in heart failure: ivabradine or beta blockers? , 2013, Heart Failure Reviews.

[14]  A. Moorman,et al.  Gene Expression Profiling of the Forming Atrioventricular Node Using a Novel Tbx3-Based Node-Specific Transgenic Reporter , 2009, Circulation research.

[15]  G. V. Van Hare,et al.  Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. , 2009, Journal of the American College of Cardiology.

[16]  A. Manolis,et al.  Ivabradine: a selective If current inhibitor in the treatment of stable angina. , 2006, Recent patents on cardiovascular drug discovery.

[17]  J. Triedman,et al.  Intravenous Amiodarone for Incessant Tachyarrhythmias in Children: A Randomized, Double-Blind, Antiarrhythmic Drug Trial , 2005, Circulation.

[18]  L. Siddoway.  Amiodarone: guidelines for use and monitoring. , 2003, American family physician.

[19]  B. Sarubbi,et al.  Visualisation of activation and repolarisation in congenital long QT syndrome , 2002, Heart.

[20]  R. Friedman,et al.  Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. , 1993, Journal of the American College of Cardiology.

[21]  A. Garson,et al.  Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. , 1990, Circulation.

[22]  P. Chiesa,et al.  [Use of ivabradine for the treatment of congenital junctional ectopic tachycardia]. , 2021, Medicina.

[23]  R. Kumar,et al.  Ivabradine in Post-operative Junctional Ectopic Tachycardia (JET): Breaking New Ground , 2019, Pediatric Cardiology.

[24]  Dario DiFrancesco,et al.  Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine , 2012, Drugs.

[25]  M. Abello,et al.  Taquicardia ectópica congénita de la unión: Tratamiento farmacológico en el primer año de vida , 2011 .

[26]  Dario DiFrancesco,et al.  Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. , 2004, Drugs.